首页>International journal of rheumatic diseases>Celecoxib, a selective cyclooxygenase-2 inhibitor, reduces level of a bone resorption marker in postmenopausal women with rheumatoid arthritis
Celecoxib, a selective cyclooxygenase-2 inhibitor, reduces level of a bone resorption marker in postmenopausal women with rheumatoid arthritis
作者单位:Department of Orthopaedic Surgery, Hoshigaoka Koseinenkin Hospital, Osaka, Japan[1]Department of Orthopaedics, Osaka University Graduate School of Medicine, Osaka, Japan[2]